Biomarin Pharmaceutical (BMRN) Q2 2016 Earnings

28AprConfirmed
Q3 2015
Q4 2015
Q1 2016
Q2 2016
-0.68
-0.09
0.51
1.1

Details

Expected EPS
-0.68
Actual EPS
-0.53
Surprise EPS
0.15
Surprise Percent
+22.06%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.53 per share for Q2 2016.

0 Comments

Share your thoughts